Close

Oppenheimer Downgrades Raptor Pharmaceuticals (RPTP) to Perform

September 25, 2013 8:08 AM EDT Send to a Friend
Oppenheimer downgraded Raptor Pharmaceuticals (NASDAQ: RPTP) from Outperform to Perform.
This article: 52 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login